Jun 29, 2026 03:00AM
Jun 29, 2026 03:00AM
May 7, 2026 04:01PM
Apr 22, 2026 06:17AM
Apr 22, 2026 06:17AM
Apr 22, 2026 06:00AM
Apr 22, 2026 06:00AM Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance
Feb 27, 2026 06:00AM
Jan 27, 2026 06:02PM
Oct 30, 2025 06:00AM
Aug 5, 2025 06:00AM
Jul 21, 2025 07:40AM
Jul 21, 2025 07:38AM
May 21, 2025 07:22AM Key Takeaways from Virtual Generics & Biosimilars Day at UBS
May 2, 2025 06:00AM
Feb 28, 2025 06:00AM
Nov 8, 2024 06:00AM
Aug 20, 2024 08:01AM
Aug 20, 2024 08:00AM
Aug 20, 2024 08:00AM
Aug 9, 2024 06:05AM Amneal Reports Second Quarter 2024 Financial Results
Aug 7, 2024 04:45PM
Jul 29, 2024 04:05PM
Jul 29, 2024 04:05PM
Jul 9, 2024 04:05PM
Jul 9, 2024 04:05PM
Jul 1, 2024 08:00AM
Jul 1, 2024 08:00AM Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)
Jun 28, 2024 08:00AM
Jun 5, 2024 08:00AM
May 22, 2024 04:35PM
May 22, 2024 04:05PM
May 3, 2024 06:00AM
Apr 24, 2024 08:00AM
Apr 24, 2024 08:00AM Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
Apr 16, 2024 08:00AM
Mar 25, 2024 04:06PM
Mar 25, 2024 04:05PM
Mar 1, 2024 06:00AM
Feb 27, 2024 08:10AM
Feb 27, 2024 08:00AM
Feb 8, 2024 04:05PM Amneal Announces Complete Response Resubmission for IPX203 New Drug Application
Jan 10, 2024 08:00AM
Jan 10, 2024 07:12AM
Jan 4, 2024 04:05PM
Dec 15, 2023 04:05PM
Dec 15, 2023 04:05PM
Dec 7, 2023 08:10AM
Dec 7, 2023 08:00AM Amneal and BIAL Announce U.S. Licensing Agreement for ONGENTYS® (opicapone)
Dec 1, 2023 08:00AM

1,168,065 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All